Dramatic regression of recalcitrant human papillomavirus type 1‐related palmar verrucae and squamous cell carcinoma in situ following R‐CHOP chemotherapy and transition to sirolimus in a renal transplant patient with diffuse large B cell lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-4632|54|5|e119-e121

ISSN： 0011-9059

Source： INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol.54, Iss.5, 2015-05, pp. : e119-e121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Deliverability and efficacy of R‐CHOP chemotherapy in very elderly patients with diffuse large B‐cell lymphoma: an Australian retrospective analysis

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 11, 2015-11 ,pp. : 1147-1153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Weekly rituximab consolidation following four cycles of R‐CHOP induction chemotherapy in very elderly patients with diffuse large B‐cell lymphoma: Consortium for improving survival of lymphoma study (CISL)

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 6, 2015-06 ,pp. : 504-510

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Value of the Pretreatment Advanced Lung Cancer Inflammation Index (ALI) in Diffuse Large B Cell Lymphoma Patients Treated with R-CHOP Chemotherapy

By  

Acta Haematologica, Vol. 137, Iss. 2, 2017-01 ,pp. : 76-85

Karger

Access to resources Recommend Favorite

Vincristine-Induced Seizure Potentiated by Itraconazole Following RCHOP Chemotherapy for Diffuse Large B-Cell Lymphoma

By  

Current Drug Safety, Vol. 7, Iss. 5, 2012-11 ,pp. : 372-374

Bentham Science Publishers

Access to resources Recommend Favorite

R-CHOP: Does One Size Fit All in Diffuse Large B Cell Lymphoma?

By  

Acta Haematologica, Vol. 131, Iss. 3, 2013-11 ,pp. : 153-155

Karger

Access to resources Recommend Favorite